⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockGermanyXETRA

BAYN.DE

Bayer Aktiengesellschaft

Healthcare · Drug Manufacturers - General

49.26EUR

-0.1500 (-0.30%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(EUR)
1)

Issue Data

Last PxEUR / 49.26
P/E—
Dvd Ind Yld0.2%
P/B1.64
P/S1.1
Curr EV/T12M EBITDA6.9
Mkt Cap (EUR)48.4B
Curr EV (EUR)81.9B
2)

Per Share Data

EPS T12M-1.76
DPS0.24
Bk Val Per Sh30.11
Rev/Sh46.19
Cash/Sh5.17
Curr Shares Out982.4M
FCF/Sh2.12
3)

Cash Flow Analysis

P/CF10.1
Curr P/FCF23.3
CF/NI-2.8
Dvd P/O-13.8%
Cash Gen/Cash Reqd1.6
Csh Dvd Cov20.0
CFO/Sales10.5%
Eff Interest Rate6.0%
4)

Growth Potential

Dil EPS 1Y Gr-41.5%
Cap 1Y Gr-14.4%
BPS 1Y Gr-18.7%
R&D To Sales12.9%
Retention Rate113.8%
Rev 1Y Gr-2.2%
FCF 1Y Gr-25.0%
Assets 1Y Gr-5.7%
5)

Profitability

EBITDA11.9B
EBIT8.2B
Operating Margin18.0%
Pretax Margin-2.7%
Net Margin-3.8%
ROA-1.6%
ROE-5.8%
ROC—
Asset Turnover0.43
6)

Structure

Current Ratio1.04
Quick Ratio0.67
Debt/Assets32.8%
Debt/Com Eq118.9%
Net Debt/EBITDA2.59
Tot Debt/Capital54.3%
Gross Margin59.1%
EBIT/Int Exp3.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.